World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

PHAS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

PhaseBio Pharmaceuticals Insider Trading History Chart

PhaseBio Pharmaceuticals Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Thousands of investors use this no cost solution | Do you?

From Insider Financial | Ad

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"

PhaseBio Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/25/2022	Enterprise Associates 13 L New	Major Shareholder	Sell	1,784,109	$0.15	$267,616.35	4,857,525
5/23/2022	Glen Burkhardt	SVP	Sell	11,248	$0.79	$8,885.92
11/19/2021	Glen Burkhardt	VP	Sell	5,766	$2.37	$13,665.42
8/18/2021	Clay Thorp	Director	Buy	10,000	$3.00	$30,000.00
5/20/2021	Glen Burkhardt	VP	Sell	3,811	$3.29	$12,538.19	3,811

A new way to collect income from stocks

From DTI | Ad

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

SEC Filings (Institutional Ownership Changes) for PhaseBio Pharmaceuticals (NASDAQ:PHAS)

49.02% of PhaseBio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

PhaseBio Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/8/2022	Resources Investment Advisors LLC.	171,150	$30K	0.0%	+959.8%	0.343%
7/19/2022	MAI Capital Management	1,709,104	$1.03M	0.0%	+20.5%	3.510%
5/17/2022	Endurant Capital Management LP	243,795	$0.32M	0.1%	-32.3%	0.501%
5/11/2022	Towercrest Capital Management	1,051,940	$1.39M	0.3%	N/A	2.160%
5/10/2022	MAI Capital Management	1,418,279	$1.87M	0.0%	N/A	2.913%
5/5/2022	Resources Investment Advisors LLC.	113,150	$0.15M	0.0%	+48.6%	0.232%
5/3/2022	Platform Technology Partners	242,473	$0.32M	0.2%	-3.7%	0.498%
2/23/2022	Resources Investment Advisors LLC.	76,150	$0.20M	0.0%	-13.6%	0.158%
2/14/2022	IPG Investment Advisors LLC	28,900	$76K	0.0%	N/A	0.060%
2/14/2022	DAFNA Capital Management LLC	378,611	$0.99M	0.2%	-37.2%	0.787%
2/11/2022	Northeast Financial Consultants Inc	37,760	$99K	0.0%	N/A	0.079%
2/10/2022	Acadian Asset Management LLC	325,395	$0.85M	0.0%	+2,492.8%	0.677%
2/8/2022	Raymond James & Associates	15,500	$40K	0.0%	N/A	0.032%
2/1/2022	Platform Technology Partners	251,723	$0.66M	0.3%	+9.8%	0.523%
1/14/2022	Spire Wealth Management	253,723	$0.66M	0.0%	N/A	0.528%
11/16/2021	Squarepoint Ops LLC	27,083	$84K	0.0%	+29.8%	0.056%
11/16/2021	Wellington Management Group LLP	4,024,658	$12.52M	0.0%	-11.3%	8.377%
11/15/2021	Pura Vida Investments LLC	27,944	$87K	0.0%	N/A	0.058%
11/15/2021	Marshall Wace LLP	218,877	$0.68M	0.0%	N/A	0.456%
11/15/2021	Eversept Partners LP	300,000	$0.93M	0.1%	N/A	0.624%
11/15/2021	Caas Capital Management LP	263,172	$0.82M	0.0%	N/A	0.548%
11/12/2021	Johnson & Johnson	1,607,044	$5M	0.4%	N/A	3.342%
11/12/2021	Jump Financial LLC	43,867	$0.14M	0.0%	N/A	0.091%
11/9/2021	BlackRock Inc.	519,359	$1.62M	0.0%	+6.6%	1.081%
11/9/2021	Candriam Luxembourg S.C.A.	1,081,258	$3.36M	0.0%	+74.6%	2.251%
11/5/2021	Resources Investment Advisors LLC.	88,150	$0.27M	0.0%	+68.1%	0.183%
9/3/2021	Parametric Portfolio Associates LLC	10,254	$38K	0.0%	N/A	0.021%
8/27/2021	Endurant Capital Management LP	2,129,709	$7.92M	2.2%	-1.6%	4.433%
8/17/2021	Millennium Management LLC	207,543	$0.77M	0.0%	N/A	0.457%
8/17/2021	Boothbay Fund Management LLC	40,564	$0.15M	0.0%	+13.0%	0.089%
8/17/2021	Bridgeway Capital Management LLC	88,600	$0.33M	0.0%	-21.3%	0.195%
8/16/2021	Squarepoint Ops LLC	20,867	$78K	0.0%	-81.4%	0.046%
8/16/2021	Cubist Systematic Strategies LLC	19,132	$71K	0.0%	N/A	0.042%
8/16/2021	Occudo Quantitative Strategies LP	14,915	$55K	0.0%	N/A	0.033%
8/16/2021	Charles Schwab Investment Management Inc.	17,190	$64K	0.0%	-47.0%	0.038%
8/16/2021	State Street Corp	79,078	$0.29M	0.0%	-77.1%	0.174%
8/16/2021	Tibra Equities Europe Ltd	91,200	$0.34M	0.1%	N/A	0.201%
8/16/2021	Goldman Sachs Group Inc.	51,297	$0.19M	0.0%	+294.3%	0.113%
8/13/2021	Northern Trust Corp	64,481	$0.24M	0.0%	-61.4%	0.142%
8/13/2021	Stifel Financial Corp	262,693	$0.98M	0.0%	+6.8%	0.578%
8/13/2021	Geode Capital Management LLC	195,860	$0.73M	0.0%	-18.9%	0.431%
8/13/2021	Vanguard Group Inc.	1,868,664	$6.95M	0.0%	+18.9%	4.112%
8/12/2021	JPMorgan Chase & Co.	76,606	$0.29M	0.0%	+8.1%	0.169%
8/12/2021	Blair William & Co. IL	17,000	$63K	0.0%	-84.0%	0.037%
8/12/2021	Ergoteles LLC	69,800	$0.26M	0.0%	N/A	0.154%
8/11/2021	BlackRock Inc.	487,024	$1.81M	0.0%	-60.1%	1.072%
8/9/2021	Resources Investment Advisors LLC.	52,450	$0.20M	0.0%	N/A	0.115%
8/5/2021	Platform Technology Partners	229,373	$0.85M	0.4%	N/A	0.505%
8/5/2021	GSA Capital Partners LLP	186,031	$0.69M	0.1%	-11.7%	0.409%
5/19/2021	Squarepoint Ops LLC	112,117	$0.39M	0.0%	N/A	0.247%
5/18/2021	RA Capital Management L.P.	2,850,000	$9.86M	0.1%	N/A	6.272%
5/17/2021	Endurant Capital Management LP	2,163,518	$7.49M	2.0%	N/A	4.761%
5/17/2021	Rock Springs Capital Management LP	1,553,974	$5.38M	0.1%	+18.2%	3.420%
5/17/2021	DAFNA Capital Management LLC	603,042	$2.09M	0.5%	+88.1%	1.327%
5/17/2021	Nuveen Asset Management LLC	80,353	$0.28M	0.0%	-18.7%	0.177%
5/17/2021	Sphera Funds Management LTD.	750,000	$2.60M	0.2%	N/A	1.650%
5/14/2021	Monashee Investment Management LLC	400,000	$1.38M	0.2%	N/A	0.880%
5/14/2021	Stifel Financial Corp	245,887	$0.85M	0.0%	+17.0%	0.541%
5/13/2021	Barclays PLC	12,754	$45K	0.0%	+159.1%	0.028%
5/13/2021	Alpine Global Management LLC	51,891	$0.18M	0.0%	N/A	0.114%
5/13/2021	Blair William & Co. IL	106,500	$0.37M	0.0%	+57.8%	0.234%
5/12/2021	Geode Capital Management LLC	241,513	$0.84M	0.0%	+4.1%	0.531%
5/12/2021	JPMorgan Chase & Co.	70,874	$0.25M	0.0%	+72.8%	0.156%
5/12/2021	UBS Group AG	8,150	$28K	0.0%	+523.1%	0.018%
5/10/2021	GSA Capital Partners LLP	210,656	$0.73M	0.1%	+50.1%	0.464%
5/7/2021	BlackRock Inc.	1,219,125	$4.22M	0.0%	+2.1%	4.141%
5/7/2021	Spire Wealth Management	50,065	$0.17M	0.0%	N/A	0.170%
5/6/2021	Altium Capital Management LP	775,000	$2.68M	0.7%	N/A	2.632%
2/24/2021	Virtu Financial LLC	28,821	$97K	0.0%	N/A	0.098%
2/19/2021	JPMorgan Chase & Co.	41,006	$0.14M	0.0%	+616.6%	0.140%
2/16/2021	ETF Managers Group LLC	14,283	$50K	0.0%	-13.1%	0.049%
2/12/2021	Stifel Financial Corp	210,125	$0.71M	0.0%	+11.9%	0.716%
2/10/2021	Rhumbline Advisers	10,492	$35K	0.0%	N/A	0.036%
2/10/2021	Renaissance Technologies LLC	83,400	$0.28M	0.0%	N/A	0.284%
2/9/2021	Wells Fargo & Company MN	24,792	$83K	0.0%	+17.8%	0.084%
2/9/2021	Bank of New York Mellon Corp	36,965	$0.13M	0.0%	-7.0%	0.126%
2/9/2021	Blair William & Co. IL	67,500	$0.23M	0.0%	N/A	0.230%
2/5/2021	BlackRock Inc.	1,193,607	$4.01M	0.0%	+5.2%	4.065%
2/4/2021	GSA Capital Partners LLP	140,341	$0.47M	0.1%	-9.1%	0.478%
11/30/2020	Platform Technology Partners	92,950	$0.33M	0.2%	+72.2%	0.317%
11/13/2020	Morgan Stanley	101,650	$0.36M	0.0%	-37.1%	0.346%
11/10/2020	State Street Corp	300,757	$1.06M	0.0%	+16.5%	1.025%
11/6/2020	BlackRock Inc.	1,134,939	$3.98M	0.0%	+4.9%	3.868%
11/6/2020	GSA Capital Partners LLP	154,316	$0.54M	0.1%	N/A	0.526%
8/31/2020	Bridgeway Capital Management Inc.	152,600	$0.70M	0.0%	-16.8%	0.520%
8/25/2020	Nuveen Asset Management LLC	32,355	$0.15M	0.0%	-23.9%	0.110%
8/20/2020	Charles Schwab Investment Management Inc.	40,648	$0.19M	0.0%	+10.5%	0.139%
8/14/2020	Bank of America Corp DE	7,171	$33K	0.0%	+73.5%	0.025%
8/14/2020	Sabby Management LLC	76,970	$0.35M	0.1%	-28.5%	0.267%
8/12/2020	Goldman Sachs Group Inc.	28,517	$0.13M	0.0%	-41.0%	0.099%
8/3/2020	Leap Investments LP	15,800	$73K	0.0%	N/A	0.055%
7/22/2020	First Trust Advisors LP	30,008	$0.14M	0.0%	+7.7%	0.104%
7/16/2020	Wedbush Securities Inc.	11,400	$52K	0.0%	N/A	0.040%
6/19/2020	State Street Corp	249,310	$0.83M	0.0%	+8.5%	0.866%
5/15/2020	Sabby Management LLC	107,577	$0.36M	0.1%	+14.0%	0.374%
5/15/2020	Morgan Stanley	85,623	$0.28M	0.0%	-16.5%	0.297%
5/15/2020	DAFNA Capital Management LLC	320,542	$1.06M	0.4%	-11.1%	1.114%
5/15/2020	Ghost Tree Capital LLC	497,074	$1.65M	0.4%	+10.5%	1.727%
5/14/2020	Wells Fargo & Company MN	16,832	$55K	0.0%	+107.0%	0.058%
5/14/2020	Geode Capital Management LLC	214,659	$0.71M	0.0%	+13.1%	0.746%

Data available starting January 2016

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiovascular diseases. The firm's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor, pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension, and PB6440, an oral agent for the treatment of resistant hypertension. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

848,888 shs

Market Capitalization

$3.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57

Who are the company insiders with the largest holdings of PhaseBio Pharmaceuticals?: PhaseBio Pharmaceuticals' top insider shareholders include:
Enterprise Associates 13 L New (Major Shareholder)
Glen Burkhardt (SVP)
Learn More about top insider investors at PhaseBio Pharmaceuticals.